Role of MYC-Regulated long noncoding RNAs in cell cycle regulation and tumorigenesis

Journal of the National Cancer Institute

Volumn 107, Issue 4, 2015, Pages

  Kim, Taewan ^a,b   Jeon, Young Jun ^b   Cui, Ri ^b   Lee, Ji Hoon ^c   Peng, Yong ^d   Kim, Sung Hak ^b,e   Tili, Esmerina ^b   Alder, Hansjuerg ^b   Croce, Carlo M ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c Seoul National University   (South Korea)

^d SICHUAN UNIVERSITY   (China)

^e Korea University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; HUR PROTEIN; LONG UNTRANSLATED RNA; MYC PROTEIN; CDKN1A PROTEIN, HUMAN; CDKN2B PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; ELAV PROTEIN; HNRNPK PROTEIN, HUMAN; MYC PROTEIN, HUMAN; RIBONUCLEOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE REGULATION; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TUMOR XENOGRAFT; ANIMAL; CELL PROLIFERATION; CELL TRANSFORMATION; COLORECTAL TUMOR; FLOW CYTOMETRY; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOPRECIPITATION; KAPLAN MEIER METHOD; METABOLISM; MORTALITY; NUDE MOUSE; REAL TIME POLYMERASE CHAIN REACTION; XENOGRAFT;

ANIMALS; CARCINOGENESIS; CELL CYCLE PROTEINS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P21; ELAV PROTEINS; FLOW CYTOMETRY; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HETEROGRAFTS; HUMANS; IMMUNOPRECIPITATION; KAPLAN-MEIER ESTIMATE; MICE; MICE, NUDE; PROTO-ONCOGENE PROTEINS C-MYC; REAL-TIME POLYMERASE CHAIN REACTION; RIBONUCLEOPROTEINS; RNA, LONG NONCODING;

EID: 84930690016     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dju505     Document Type: Article

References (27)

1. Mattick JS, Makunin IV. Small regulatory RNAs in mammals. Hum Mol Genet. 2005;14 Spec No 1:R121-R132.
2. Guttman M, Rinn JL. Modular regulatory principles of large non-coding RNAs. Nature. 2012;482(7385):339-346.
3. Khalil AM, Guttman M, Huarte M, et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A. 2009;106(28):11667-11672.
4. Orom UA, Derrien T, Beringer M, et al. Long noncoding RNAs with enhancerlike function in human cells. Cell. 2010;143(1):46-58.
5. Rinn JL, Kertesz M, Wang JK, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell. 2007;129(7):1311-1323.
6. Calin GA, Liu CG, Ferracin M, et al. Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell. 2007;12(3):215-229.
7. Ling H, Spizzo R, Atlasi Y, et al. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res. 2013;23(9):1446-1461.
8. Nissan A, Stojadinovic A, Mitrani-Rosenbaum S, et al. Colon cancer associated transcript-1: a novel RNA expressed in malignant and pre-malignant human tissues. Int J Cancer. 2012;130(7):1598-1606.
9. Kim T, Cui R, Jeon YJ, et al. Long-range interaction and correlation between MYC enhancer and oncogenic long noncoding RNA CARLo-5. Proc Natl Acad Sci U S A. 2014;111(11):4173-4178.
10. Dang CV. MYC on the Path to Cancer. Cell. 2012;149(1):22-35.
11. Muzny DM, et al. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487(7407):330-337.
12. Seoane J, Pouponnot C, Staller P, Schader M, Eilers M, Massague J. TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b. Nat Cell Biol. 2001;3(4):400-408.
13. Inoue S, Hao Z, Elia AJ, et al. Mule/Huwe1/Arf-BP1 suppresses Ras-driven tumorigenesis by preventing c-Myc/Miz1-mediated down-regulation of p21 and p15. Genes Dev. 2013;27(10):1101-1114.
14. Staller P, Peukert K, Kiermaier A, et al. Repression of p15INK4b expression by Myc through association with Miz-1. Nat Cell Biol. 2001;3(4):392-399.
15. Oskarsson T, Essers MA, Dubois N, et al. Skin epidermis lacking the c-Myc gene is resistant to Ras-driven tumorigenesis but can reacquire sensitivity upon additional loss of the p21Cip1 gene. Genes Dev. 2006;20(15):2024-2029.
16. Rochlitz CF, Herrmann R, de Kant E. Overexpression and amplification of c-myc during progression of human colorectal cancer. Oncology. 1996;53(6):448-454.
17. Lee BK, Bhinge AA, Battenhouse A, et al. Cell-type specific and combinatorial usage of diverse transcription factors revealed by genome-wide binding studies in multiple human cells. Genome Res. 2011;22(1):9-24.
18. Muppirala UK, Honavar VG, Dobbs D. Predicting RNA-protein interactions using only sequence information. BMC Bioinformatics. 2011;12:489.
19. Gao R, Yu Y, Inoue A, Widodo N, Kaul SC, Wadhwa R. Heterogeneous nuclear ribonucleoprotein K (hnRNP-K) promotes tumor metastasis by induction of genes involved in extracellular matrix, cell movement, and angiogenesis. J Biol Chem. 2006;288(21):15046-15056.
20. Carpenter B, McKay M, Dundas SR, Lawrie LC, Telfer C, Murray GI. Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer. Br J Cancer. 2006;95(7):921-927.
21. Wang J, Guo Y, Chu H, Guan Y, Bi J, Wang B. Multiple Functions of the RNA-Binding Protein HuR in Cancer Progression, Treatment Responses and Prognosis. Int J Mol Sci. 2013;14(5):10015-10041.
22. Newbold A, Salmon JM, Martin BP, Stanley K, Johnstone RW. The role of p21 and p27 in HDACi-mediated tumor cell death and cell cycle arrest in the Emu-myc model of B-cell lymphoma. Oncogene. 2013;33:5415-5423.
23. Zhang J, Lou X, Yang S, et al. BAG2 is a target of the c-Myc gene and is involved in cellular senescence via the p21(CIP1) pathway. Cancer Lett. 2011;318(1):34-41.
24. Liu M, Casimiro MC, Wang C, et al. p21CIP1 attenuates Ras-and c-Mycdependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo. Proc Natl Acad Sci U S A. 2009;106(45):19035-19039.
25. Carnero A, Beach DH. Absence of p21WAF1 cooperates with c-myc in bypassing Ras-induced senescence and enhances oncogenic cooperation. Oncogene. 2004;23(35):6006-6011.
26. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663-676.
27. Zheng GX, Do BT, Webster DE, Khavari PA, Chang HY. Dicer-microRNA-Myc circuit promotes transcription of hundreds of long noncoding RNAs. Nat Struct Mol Biol. 2014;21(7):585-590.